| NEOGENOMICS INC. |
| USA |
| Gesundheit |
| US64049M2098 / 120159 |
| NG9 (Frankfurt) / NEO (NASDAQ) |
| FRA:NG9, ETR:NG9, NG9:GR, NASDAQ:NEO |
| - |
| https://www.neogenomics.c.. |
|
NeoGenomics Inc. is a prominent player in the healthcare and pharmaceutical industry, specializing in cancer diagnostics and related genetic testing services. The company offers a comprehensive range ..
>Volltext.. |
| 1240.6 Mio. EUR |
| 1450.42 Mio. EUR |
| 597.51 Mio. EUR |
| -3.36 Mio. EUR |
| -95.6 Mio. EUR |
| -0.75 EUR |
| 345.71 Mio. EUR |
| 138.28 Mio. EUR |
| 11.53 Mio. EUR |
| 1.68 |
| 4.47% |
| -38.51% |
| - |
| - |
| - |
| NEOGENOMICS |
| 17.02.26 |